Literature DB >> 29326351

NK cell destiny after haploSCT with PT-Cy.

Amnon Peled1, Arnon Nagler2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29326351      PMCID： PMC5757679          DOI： 10.1182/blood-2017-10-811117

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts.

Authors:  Claudio G Brunstein; Ephraim J Fuchs; Shelly L Carter; Chatchada Karanes; Luciano J Costa; Juan Wu; Steven M Devine; John R Wingard; Omar S Aljitawi; Corey S Cutler; Madan H Jagasia; Karen K Ballen; Mary Eapen; Paul V O'Donnell
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

2.  Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Authors:  Loredana Ruggeri; Antonella Mancusi; Marusca Capanni; Elena Urbani; Alessandra Carotti; Teresa Aloisi; Martin Stern; Daniela Pende; Katia Perruccio; Emanuela Burchielli; Fabiana Topini; Erika Bianchi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Authors:  Jeffrey S Miller; Yvette Soignier; Angela Panoskaltsis-Mortari; Sarah A McNearney; Gong H Yun; Susan K Fautsch; David McKenna; Chap Le; Todd E Defor; Linda J Burns; Paul J Orchard; Bruce R Blazar; John E Wagner; Arne Slungaard; Daniel J Weisdorf; Ian J Okazaki; Philip B McGlave
Journal:  Blood       Date:  2005-01-04       Impact factor: 22.113

Review 4.  A review of infectious complications after haploidentical hematopoietic stem cell transplantations.

Authors:  Erden Atilla; Pinar Ataca Atilla; Sinem Civriz Bozdağ; Taner Demirer
Journal:  Infection       Date:  2017-04-17       Impact factor: 3.553

Review 5.  Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation.

Authors:  Antonella Mancusi; Loredana Ruggeri; Andrea Velardi
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

6.  NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

Authors:  Antonio Russo; Giacomo Oliveira; Sofia Berglund; Raffaella Greco; Valentina Gambacorta; Nicoletta Cieri; Cristina Toffalori; Laura Zito; Francesca Lorentino; Simona Piemontese; Mara Morelli; Fabio Giglio; Andrea Assanelli; Maria Teresa Lupo Stanghellini; Chiara Bonini; Jacopo Peccatori; Fabio Ciceri; Leo Luznik; Luca Vago
Journal:  Blood       Date:  2017-10-06       Impact factor: 22.113

Review 7.  Overview of the progress on haploidentical hematopoietic transplantation.

Authors:  Nosha Farhadfar; William J Hogan
Journal:  World J Transplant       Date:  2016-12-24

8.  Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

Authors:  R Crocchiolo; S Bramanti; A Vai; B Sarina; R Mineri; E Casari; F Tordato; E Mauro; I Timofeeva; E Lugli; D Mavilio; C Carlo-Stella; A Santoro; L Castagna
Journal:  Transpl Infect Dis       Date:  2015-04       Impact factor: 2.228

9.  Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.

Authors:  Franco Locatelli; Daniela Pende; Maria C Mingari; Alice Bertaina; Michela Falco; Alessandro Moretta; Lorenzo Moretta
Journal:  Front Immunol       Date:  2013-02-01       Impact factor: 7.561

Review 10.  Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Catherine J Lee; Bipin N Savani; Mohamad Mohty; Myriam Labopin; Annalisa Ruggeri; Christoph Schmid; Frédéric Baron; Jordi Esteve; Norbert C Gorin; Sebastian Giebel; Fabio Ciceri; Arnon Nagler
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.